Literature DB >> 15472713

Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L.

Bastien Calmels1, Stéphane Paul, Nicolas Futin, Catherine Ledoux, Fabienne Stoeckel, Bruce Acres.   

Abstract

Recent evidence has resurrected the concept of specialized populations of T lymphocytes that are able to suppress an antigen-specific immune response. T-regulatory cells (T-reg) have been characterized as CD4+ CD25+ T cells. Previous reports describing differential gene expression analysis have shown that the glucocorticoid-induced tumor necrosis family receptor family-related gene (GITR) is upregulated in these cells. Furthermore, antibodies specific for GITR have been shown to inhibit the T-suppressor function of CD4+ CD25+ T-reg. The ligands for both mouse and human GITR have been cloned recently. We have inserted the sequences for natural, membrane-bound GITR-ligand (GITR-L) and a truncated secreted form of GITR-L (GITR-Lsol) into the adenovirus-5 genome. Coculture experiments show that cells infected with Ad-GITR-L and supernatants from cells infected with Ad-GITR-Lsol can increase the proliferation of both CD4+ CD25- and CD8+ T cells in response to anti-CD3 stimulation, in the presence, as well as in the absence, of CD4+ CD25+ T cells. The virus constructs were injected into growing B16 melanoma tumors. Ad-GITR-L was shown to attract infiltration with both CD4+ and CD8+ T cells. Both constructs were shown to inhibit tumor growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15472713     DOI: 10.1038/sj.cgt.7700781

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  19 in total

1.  Lipid Metabolism and Immune Checkpoints.

Authors:  Qianjin Liao; Yujuan Zhou; Longzheng Xia; Deliang Cao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.

Authors:  Giuseppe Nocentini; Simona Ronchetti; Maria Grazia Petrillo; Carlo Riccardi
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

4.  Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours.

Authors:  Jinhua Piao; Yosuke Kamimura; Hideyuki Iwai; Yujia Cao; Keisuke Kikuchi; Masaaki Hashiguchi; Taro Masunaga; Hongsi Jiang; Kouichi Tamura; Shimon Sakaguchi; Miyuki Azuma
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

Review 5.  Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.

Authors:  K S Peggs; S A Quezada; J P Allison
Journal:  Clin Exp Immunol       Date:  2009-02-18       Impact factor: 4.330

6.  Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.

Authors:  John S Cho; Jeffrey V Hsu; Sherie L Morrison
Journal:  Cancer Immunol Immunother       Date:  2008-11-19       Impact factor: 6.968

7.  Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.

Authors:  Zhaocai Zhou; Xiaomin Song; Alan Berezov; Geng Zhang; Yanjing Li; Hongtao Zhang; Ramachandran Murali; Bin Li; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

Review 8.  Integrating costimulatory agonists to optimize immune-based cancer therapies.

Authors:  Angela D Pardee; Amy K Wesa; Walter J Storkus
Journal:  Immunotherapy       Date:  2009-03       Impact factor: 4.196

9.  Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligation.

Authors:  Zuqiang Liu; Shenghe Tian; Louis D Falo; Shimon Sakaguchi; Zhaoyang You
Journal:  Mol Ther       Date:  2009-05-05       Impact factor: 11.454

Review 10.  Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.

Authors:  Theresa Placke; Hans-Georg Kopp; Helmut Rainer Salih
Journal:  Clin Dev Immunol       Date:  2010-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.